Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 12-2018 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,962 | 0 | 312,600 | 304,400 | 274,000 |
| Cost of Goods | N/A | N/A | 199,700 | 191,400 | 174,100 |
| Gross Profit | 1,962 | N/A | 112,900 | 113,000 | 99,900 |
| Operating Expenses | 25,849 | 0 | 98,000 | 87,200 | 91,800 |
| Operating Income | -23,887 | N/A | 15,600 | 26,200 | 8,200 |
| Interest Expense | 36 | 0 | 0 | 0 | 0 |
| Other Income | 669 | 0 | -1,000 | 51,500 | -19,900 |
| Pre-tax Income | -23,254 | 0 | 14,600 | 77,700 | -11,700 |
| Income Tax | 94 | N/A | 3,000 | 1,900 | 800 |
| Net Income Continuous | -23,348 | N/A | 11,600 | 75,800 | -12,500 |
| Net Income Discontinuous | N/A | N/A | -300 | -100 | -200 |
| Minority Interests | N/A | N/A | 800 | -100 | 400 |
| Net Income | $-23,348 | $N/A | $10,500 | $75,800 | $-13,100 |
| EPS Basic Total Ops | -0.49 | N/A | 0.12 | 0.78 | -0.14 |
| EPS Basic Continuous Ops | -0.49 | N/A | 0.11 | 0.78 | -0.13 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.49 | N/A | 0.20 | 0.68 | -0.14 |
| EPS Diluted Continuous Ops | -0.49 | N/A | 0.19 | 0.68 | -0.13 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-23,887 | $N/A | $31,300 | $42,000 | $24,900 |